마취 기기 시장 예측(-2028년) - 제품, 용도, 최종사용자 및 지역별 세계 분석

According to Stratistics MRC, the Global Anesthesia Devices Market is accounted for $17.77 billion in 2022 and is expected to reach $34.64 billion by 2028 growing at a CAGR of 11.77% during the forecast period. During surgical procedures, anesthesia devices are used to control breathing, blood pressure, blood flow, heart rate, and rhythm. Anesthesia-induced medical conditions, such as analgesia, paralysis, amnesia, or unconsciousness, cause patients to lose feeling or awareness. In order to administer gases to patients wearing oxygen masks, these machines deliver variable gas mixtures, which are then delivered to the breathing systems. Anesthetic machines control the mixture of gases that are given to patients, which includes oxygen, nitrous oxide, and other gases.

According to an article published by PubMed Central in July 2022, a study was conducted where an intelligence model was developed that helped in predicting the depth of anesthesia from a single-channel electroencephalograph (EEG) signal. Thus, the development of such newer technologies is also expected to enhance the market's growth.

Market Dynamics:

Driver:

Increasing geriatric population prone to chronic diseases

A significant factor actively influencing the growth of the studied market is the rising geriatric population, which is susceptible to chronic diseases. For instance, 7.6 million people in the UK are estimated to be affected by heart or circulatory diseases, according to the British Heart Foundation Factsheet, which was published in August 2022. According to the same source, in the United Kingdom, more than half of people will experience a heart or circulatory condition at some point in their lives, and roughly twice as many people are living with these conditions. A rise in the number of surgical procedures requiring anesthesia, an increase in the number of such procedures, the prevalence of chronic diseases, and the rising geriatric population are the main factors promoting the market's growth.

Restraint:

Intense competition among vendors

One of the main obstacles preventing market expansion is the fierce competition among vendors. The abundance of local and international vendors makes the market for anesthesia equipment competitive worldwide. A wide range of products are offered by leading suppliers, who also have the necessary technical, financial, and marketing resources, a strong geographic footprint, and significant R&D expenditures. Small and medium-sized suppliers, on the other hand, have constrained financial and technical resources in addition to constrained product offerings. Therefore, during the projected period, these factors will restrain the growth of the global market.

Opportunity:

Rising technological innovations

The market's expansion is also anticipated to be aided by the growing number of technological advancements in anesthesia monitoring technology. For instance, a study was conducted where an intelligence model was created to aid in predicting the depth of anesthesia from a single-channel electroencephalograph (EEG) signal, according to an article published by PubMed Central in July 2022. Therefore, it is anticipated that the development of these newer technologies will also accelerate market expansion.

Threat:

Phasing out coal based energy

One of the key factors limiting the growth of the global anesthesia market over the forecast period is the rising number of product recalls resulting in serious injuries or fatalities. For instance, AMSORB PLUS PREFILLED G-CAN 1.0L is recalled by hospital equipment manufacturer Armstrong Medical Limited in September 2021 due to the patients' reduced gas flow during anesthesia. This is a Class I recall, the most serious category of recall, according to the FDA. The use of these devices could result in fatalities or severe injuries. The pre-use or "CHECK-OUT" test on the anesthesia machine could fail as a result of the flow issues. Such serious issues limit market growth.

COVID-19 Impact:

The COVID-19 outbreak has expanded outside of the initial Chinese outbreak, and the World Health Organization (WHO) has declared a pandemic situation. Hospital activities have drastically decreased as a result of the epidemic situation. Due to the rising COVID-19 cases in the early stages of the pandemic, all hospitals worldwide cancelled all planned and elective surgeries. As a result of the pandemic, patient monitoring and chronic disease management were severely disrupted; many patients were unable to visit hospitals, and surgeries were postponed. The decrease in unnecessary surgeries has driven the market's expansion. Additionally, the market for anesthesia devices was positively impacted by the fact that anesthesia devices were also used to ventilate COVID-19 patients.

The orthopedics segment is expected to be the largest during the forecast period

In 2020, the orthopedics industry dominated the market and is estimated to hold the dominant position throughout the forecast period. This is attributed to an increase in the incidence and prevalence of orthopedic disorders, a growing elderly population, rising public awareness of the need for orthopedic surgery, and ongoing technological advancements that are encouraging an increase in orthopedic surgery, which will support the growth of the anesthesia devices market.

The delivery machine segment is expected to have the highest CAGR during the forecast period

During the anticipated period, the delivery machine segment's market share growth will be significant. The continuous or intermittent administration of an anesthetic agent to a patient while maintaining ventilation is done with the aid of anesthesia delivery machines. Mobile and stationary anesthesia delivery systems are both types of anesthesia delivery systems. The anesthesia machine, which is mounted on the ceiling and has one or more articulated arms, can be easily moved to different locations without littering the floor with cables and tubes. These benefits will cause the demand for self-contained anesthesia machines to increase over the course of the forecast period.

Region with largest share:

Due to the rapid rise in diseases like obesity, cardiovascular issues, and various cancers, which has led to an increase in the number of open and minimally invasive surgeries, North America is anticipated to account for a sizeable portion of the global market throughout the forecast period. Additionally, the region's anesthesia device market is expanding due to the rise in minimally invasive surgeries for chronic diseases. In a similar vein, the Canadian Cancer Society predicted in November 2022 that 233,900 people would receive a cancer diagnosis that year. The aging and expanding population of Canada is largely to blame for this increase in incidence. Therefore, over the course of the forecast period, the rising incidence of cancer is anticipated to increase the use of anesthesia devices and fuel market growth in this region.

Region with highest CAGR:

A large patient base, an expanding healthcare system, a growing geriatric population, and an increase in surgeries have all contributed to the market's lucrative growth in the Asia-Pacific region. Owing to its extensive health insurance system, rapid economic growth, rising demand for intermittent flow anesthetic machines, rising rates of surgeries like bariatric and cardiovascular procedures, and rising cancer cases, China currently holds the largest market share. Additionally, a rise in medical travel due to the inexpensive medical care provided by nations like China and India will boost regional growth.

Key players in the market:

Some of the key players profiled in the Anesthesia Devices Market include 3M Company, Airsep Corporation, Ambu A/S, B. Braun Melsungen AG, Becton Dickinson, CAIRE Inc., Dragerwerk AG & Co. KGaA, Fisher & Paykel Healthcare, GE Healthcare, ICU Medical, Inc., Karl Storz GmbH & Co. KG, Koninklijke Philips N.V., Medtronic PLC, Smiths Group, SunMed, Teleflex Incorporated and Ventlab.

Key Developments:

In May 2022, Fisher & Paykel Healthcare Corporation Limited launched two new products developed specifically for use in anesthesia applications. The company released the Optiflow Switch and Optiflow Trace nasal high-flow interface devices into select markets following several years of R&D.

In April 2022, Ambu announces that Ambu® aScope™ Gastro and Ambu® aBox™ 2 have received CE mark and market clearance for Japan, and Ambu will expand the global launch of its single-use gastroscope and next-generation display ecosystem to include Europe and Japan. Gastroscopy is a segment where more than 20 million procedures take place annually with reusable endoscope systems, and Ambu enters this market to address the current limitations of reusable endoscopes.

In March 2022, B. Braun acquires Intermedt Medizin & Technik GmbH, a specialist in the preparation of dialysis concentrates. With the full integration of Intermedt Medizin & Technik GmbH into the Group, B. Braun has completed the extensive product portfolio of its B. Braun Avitum division as a systems provider for extracorporeal blood treatment (dialysis).

Products Covered:

• Delivery Machine
• Advanced Monitors
• Disposables & Accessories
• Basic Anesthesia Monitors
• Vaporizers
• Disposables
• Information Management Systems
• Integrated Workstation
• Others Products

Applications Covered:

• Cardiology
• Dental
• Neurology
• Ophthalmology
• Orthopedics
• Urology
• Other Applications

End Users Covered:

• Ambulatory Service Centres
• Clinics
• Hospital

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2020, 2021, 2022, 2025, and 2028
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Product Analysis
• 3.7 Application Analysis
• 3.8 End User Analysis
• 3.9 Emerging Markets
• 3.10 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Anesthesia Devices Market, By Product

• 5.1 Introduction
• 5.2 Delivery Machine
• 5.3 Advanced Monitors
  • 5.3.1 Gas Monitors
  • 5.3.2 Standalone Capnography Monitors
  • 5.3.3 Other Advanced Monitors
• 5.4 Disposables & Accessories
  • 5.4.1 Anesthesia Circuits
  • 5.4.2 Anesthesia Masks
  • 5.4.3 Laryngoscopes
  • 5.4.4 Other Disposables & Accessories
• 5.5 Basic Anesthesia Monitors
• 5.6 Vaporizers
• 5.7 Disposables
• 5.8 Information Management Systems
• 5.9 Integrated Workstation
• 5.10 Others Products

6 Global Anesthesia Devices Market, By Application

• 6.1 Introduction
• 6.2 Cardiology
• 6.3 Dental
• 6.4 Neurology
• 6.5 Ophthalmology
• 6.6 Orthopedics
• 6.7 Urology
• 6.8 Other Applications

7 Global Anesthesia Devices Market, By End User

• 7.1 Introduction
• 7.2 Ambulatory Service Centres
• 7.3 Clinics
• 7.4 Hospital

8 Global Anesthesia Devices Market, By Geography

• 8.1 Introduction
• 8.2 North America
  • 8.2.1 US
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 Italy
  • 8.3.4 France
  • 8.3.5 Spain
  • 8.3.6 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 Japan
  • 8.4.2 China
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 New Zealand
  • 8.4.6 South Korea
  • 8.4.7 Rest of Asia Pacific
• 8.5 South America
  • 8.5.1 Argentina
  • 8.5.2 Brazil
  • 8.5.3 Chile
  • 8.5.4 Rest of South America
• 8.6 Middle East & Africa
  • 8.6.1 Saudi Arabia
  • 8.6.2 UAE
  • 8.6.3 Qatar
  • 8.6.4 South Africa
  • 8.6.5 Rest of Middle East & Africa

9 Key Developments

• 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 9.2 Acquisitions & Mergers
• 9.3 New Product Launch
• 9.4 Expansions
• 9.5 Other Key Strategies

10 Company Profiling

• 10.1 3M Company
• 10.2 Airsep Corporation
• 10.3 Ambu A/S
• 10.4 B. Braun Melsungen AG
• 10.5 Becton Dickinson
• 10.6 CAIRE Inc.
• 10.7 Dragerwerk AG & Co. KGaA
• 10.8 Fisher & Paykel Healthcare
• 10.9 GE Healthcare
• 10.10 ICU Medical, Inc.
• 10.11 Karl Storz GmbH & Co. KG
• 10.12 Koninklijke Philips N.V.
• 10.13 Medtronic PLC
• 10.14 Smiths Group
• 10.15 SunMed
• 10.16 Teleflex Incorporated
• 10.17 Ventlab